Benefits of Aerobic and/or Resistance Training in HIV-Positive Patients: A Systematic Review

被引:2
|
作者
Souza, Hugo Fabio [1 ,2 ,3 ]
Marques, Debora Cristina [1 ,2 ]
机构
[1] UNI BH, Grad Ctr Univ Belo Horizonte, Belo Horizonte, MG, Brazil
[2] Fac UNI BH, Belo Horizonte, MG, Brazil
[3] Acad Corpo Posith, Portadores HIV, Belo Horizonte, MG, Brazil
关键词
HIV/AIDS; endurance training; aerobic exercise; resistance training; strength training; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; QUALITY-OF-LIFE; INFECTED PATIENTS; BODY-COMPOSITION; RISK-FACTORS; EXERCISE; LIPODYSTROPHY; FAT; PATHOGENESIS;
D O I
10.1590/S1517-86922009000700013
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
AIDS is considered a chronic disease, characterized for depletion of the lymphocyte T CD4+, caused by the HIV virus. The HIV infection and its pharmacological treatment are linked to physiological and physical disorders, which can induce to lower quality of life. Therefore, the purpose of this work was to elaborate a systematic review about studies published in Pubmed and Capes between 1998 and 2008, which investigated physiological, metabolic, psychological and immunological changes mediated by aerobic and strength training in seropositive individuals. Protocols which only used either aerobic or strength training and both of them were discussed. Most of the research found favorable results about those variables studied. Concerning the prescription model for this population, it should be composed of strength exercises, from 8 to 15 maximum repetitions (hypertrophy) and of aerobic exercises (continuous or interval) with duration of 20 to 60 minutes, the intensity must be between 50-85% of maximum heart rate or 45-80% of maximum oxygen consumption, both three to five times a week. Therefore, in order to develop a program of physical activity it is very important to know the present physical and physiological condition of the HIV+ subject, so that his exertion condition is not under or overestimated.
引用
收藏
页码:467 / 471
页数:5
相关论文
共 50 条
  • [21] PROSTATE CANCER IN HIV-POSITIVE PATIENTS: A REVIEW OF THE LITERATURE
    Facciola, A.
    Ceccarelli, M.
    Rullo, E. Venanzi
    D'Aleo, F.
    Condorelli, F.
    Visalli, G.
    Cacopardo, B.
    Pinzone, M. R.
    Di Rosa, M.
    Nunnari, G.
    Pellicano, G. F.
    WORLD CANCER RESEARCH JOURNAL, 2018, 5 (03)
  • [22] Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
    Bondarenko, Vasily
    Buynevich, Irina
    Holyavkin, Andrey
    Goponyako, Svetlana
    Burinsky, Nkolaj
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis
    Ahmadpour, Ehsan
    Safarpour, Hanie
    Xiao, Lihua
    Zarean, Mehdi
    Hatam-Nahavandi, Kareem
    Barac, Aleksandra
    Picot, Stephane
    Rahimi, Mohammad Taghi
    Rubino, Salvatore
    Mahami-Oskouei, Mahmoud
    Spotin, Adel
    Nami, Sanam
    Baghi, Hossein Bannazadeh
    PARASITE, 2020, 27
  • [24] A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients
    Patton, LL
    Bonito, AJ
    Shugars, DA
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2001, 92 (02): : 170 - 179
  • [25] COVID-19 in HIV-positive patients: A systematic review of case reports and case series
    Heidary, Mohsen
    Asadi, Arezoo
    Noorbakhsh, Negar
    Dashtbin, Shirin
    Asadollahi, Parisa
    Dranbandi, Atieh
    Navidifar, Tahereh
    Ghanavati, Roya
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (04)
  • [26] Re: Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis
    Atashili, J.
    Kalilani, L.
    HIV MEDICINE, 2009, 10 (01) : 60 - 60
  • [27] Burden, Determinants, and Pharmacological Management of Hypertension in HIV-Positive Patients and Populations: A Systematic Narrative Review
    Kim Anh Nguyen
    Peer, Nasheeta
    Mills, Edward J.
    Kengne, Andre Pascal
    AIDS REVIEWS, 2015, 17 (02) : 83 - 95
  • [28] The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence
    SeyedAlinaghi, SeyedAhmad
    Karimi, Amirali
    MohsseniPour, Mehrzad
    Barzegary, Alireza
    Mirghaderi, Seyed Peyman
    Fakhfouri, Amirata
    Saeidi, Solmaz
    Razi, Armin
    Mojdeganlou, Hengameh
    Tantuoyir, Marcarious M.
    Afsahi, Amir Masoud
    Mehraeen, Esmaeil
    Dadras, Omid
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1160 - 1185
  • [29] Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review
    Hill, Andrew
    Clayden, Polly
    Thorne, Claire
    Christie, Rachel
    Zash, Rebecca
    JOURNAL OF VIRUS ERADICATION, 2018, 4 (02) : 66 - 71
  • [30] CLINICS FOR HIV-POSITIVE PATIENTS
    HAWKINS, D
    PRACTITIONER, 1989, 233 (1478) : 1449 - &